TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Viral Vector & Plasmid DNA Manufacturing Market to Surpass USD 27.71 Billion by 2034

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Nova One Advisor
Viral Vector & Plasmid DNA Manufacturing Market to Surpass USD 27.71 Billion by 2034

The global viral vector & plasmid DNA manufacturing market is projected to grow from $7.54 billion in 2025 to $27.71 billion by 2034, driven by increasing demand for gene therapies, vaccines, and advanced biologics, with a compound annual growth rate of 15.57%.

Insights
RGTIW   positive

Technical milestones in qubit performance, vertical integration, substantial cash reserves, and innovative chiplet-based scaling strategy


TMO   positive

Leading global supplier of plasmid DNA and viral vectors with end-to-end solutions, supporting gene therapy developers worldwide